AUSTEDO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Aug 2023)
What this means for you
Registered since 13 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86492763
- Registration number
- 5223588
- Mark type
- Stylized text
- Filed
- 30 Dec 2014
- Published for opposition
- 15 Sept 2015
- Registered
- 13 Jun 2017
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders
Owner
- AUSPEX PHARMACEUTICALS LLC, PARSIPPANY, NJ, US
- Auspex Pharmaceuticals, Inc., Parsippany, NJ, US
- Auspex Pharmaceuticals, Inc., La Jolla, CA, US
- Auspex Pharmaceuticals, Inc., La Jolla, CA, US
Prosecution history
- 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Aug 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Aug 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Aug 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Feb 2023 — TEAS SECTION 8 & 15 RECEIVED
- 13 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jul 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 Jul 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Jul 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 May 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Apr 2017 — USE AMENDMENT FILED
- 24 Apr 2017 — TEAS STATEMENT OF USE RECEIVED